CoCr Sirolimus-eluting Coronary Stent System
- UID
- IMP/MD/2020/000472_6cea38a486394e3a2ed0c96d2c216ced_54df1f63c9636651c1709d6d87042328
- Device class
- Class D
- Brand name
- Ultraskin
- License holder
- M/s LepuCare (India) Vascular Solutions Pvt. Ltd.,
- Approving authority
- CDSCO
- Product information
- GuReater™ CoCr Sirolimus-eluting Coronary Stent system are indicated for improving coronary luminal diameter in the following: • Patients with symptomatic ischemic heart disease due to de novo native coronary artery lesions (Ultraskin) with reference vessel diameters ranging from 2.25 mm to 4.5 mm; • Patients with restoring acute coronary occlusion or endangered coronary occlusion during percutaneous coronary intervention; • Patients with acute coronary artery syndrome (Ultraskin) relevant lesions; • Patients with vascular dissection and/or laceration
CoCr Sirolimus-eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000472_6cea38a486394e3a2ed0c96d2c216ced_54df1f63c9636651c1709d6d87042328. This device is marketed under the brand name Ultraskin. The license holder is M/s LepuCare (India) Vascular Solutions Pvt. Ltd.,, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.